Early-stage life science companies headquartered or operating in Massachusetts can apply by Oct 30, 2026 for grants (typically $75k-$100k, max $150k) for regulatory, market, reimbursement, manufacturing and IP commercialization work.
Access and Accelerate helps early-stage Massachusetts life science companies overcome go-to-market and commercialization barriers by funding work such as market assessments, FDA and regulatory strategy, reimbursement and payer analyses, manufacturing readiness and IP landscape reviews. Awards are typically $75,000-$100,000 and may not exceed $150,000, with 80% paid on execution of the grant agreement and 20% on a reimbursement basis. The current application period runs October 5 - October 30, 2026 at 1 p.m. EST.
Applicants must be headquartered or have significant operations in Massachusetts.
Must be developing an innovative life science technology and demonstrate a defined commercialization milestone.
Eligible sectors include therapeutics, diagnostics, medical devices, digital health, research tools, platform technologies and enabling technologies.
Topics
Money can be used for
Open opportunities funding similar work, from the same funder or in the same place.
Only accredited Historically Black Colleges and Universities with faculty conducting research in science, engineering, or STEM education may apply. NSF funds research projects aligned with its research programs to build…
Invitation-only BJA/ATF program funding state, local, and tribal law enforcement agencies at 194 pre-listed jurisdictions to replace outdated NIBIN ballistic imaging equipment and cover five years of maintenance,…
Funds translation of promising preclinical burn-care findings into products—medical devices, drugs, clinical practice guidelines—for use in austere, resource-limited military operational settings. Open to any entity…
DARPA SBIR Phase I/II contract topic open only to US for-profit small businesses (500 or fewer employees, majority US-owned, SAM.gov registered). Funds development of a noninvasive sensing plus AI device that lets…
DoD STTR Phase I/II contract topic for US small businesses (500 or fewer employees) developing scalable, cost-effective roll-to-roll processing of large-area, oriented 2-dimensional polymer films (e.g., COFs) with…
DoD STTR Phase I/II contract for US small businesses (500 or fewer employees) partnering with a US nonprofit research institution or university. Funds R&D of a lightweight expeditionary solar refinery that synthesizes…